Global MHC-Peptide Tetramer Market Insights, Forecast to 2031

Global MHC-Peptide Tetramer market size in terms of revenue is projected to reach 382.44 million USD by 2031 from 194.40 million USD in 2024, with a CAGR 10.50% during 2025-2031.

North America market for MHC-Peptide Tetramer is estimated to increase from 63.45 million USD in 2024 to reach 116.42 million USD by 2031, at a CAGR of 9.80% during the forecast period of 2025 through 2031.

Europe market for MHC-Peptide Tetramer is estimated to increase from 51.14 million USD in 2024 to reach 97.84 million USD by 2031, at a CAGR of 9.79% during the forecast period of 2025 through 2031.

Asia-Pacific market for MHC-Peptide Tetramer is estimated to increase from 75.68 million USD in 2024 to reach 160.05 million USD by 2031, at a CAGR of 11.48% during the forecast period of 2025 through 2031.

The major global manufacturers of MHC-Peptide Tetramer include BioLegend (Revvity), MBL Life Science (JSR Corporation), ImmunAware, ProImmune, MedChemExpress (MCE), Creative Biolabs, WuXi AppTec, KACTUS, Creative Biosciences, ACROBiosystems, etc. In 2024, the world's top five vendors accounted for approximately 49.53% of the revenue.

Report Includes

This report presents an overview of global market for MHC-Peptide Tetramer market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of MHC-Peptide Tetramer, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for MHC-Peptide Tetramer, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the MHC-Peptide Tetramer revenue, market share and industry ranking of main companies, data from 2020 to 2024. Identification of the major stakeholders in the global MHC-Peptide Tetramer market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for MHC-Peptide Tetramer revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including BioLegend (Revvity), MBL Life Science (JSR Corporation), ImmunAware, ProImmune, MedChemExpress (MCE), Creative Biolabs, WuXi AppTec, KACTUS, Creative Biosciences, ACROBiosystems, etc.

Market Segmentation

By Company

• BioLegend (Revvity)
• MBL Life Science (JSR Corporation)
• ImmunAware
• ProImmune
• MedChemExpress (MCE)
• Creative Biolabs
• WuXi AppTec
• KACTUS
• Creative Biosciences
• ACROBiosystems
• ChemPartner

Segment by Type

• MHC-I
• MHC-II

Segment by Application

Infectious Disease Research

• Cancer Immunology
• Other

By Region

North America

• United States
• Canada
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia-Pacific

Europe

• Germany
• France
• U.K.
• Italy
• Russia
• Rest of Europe
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of MHC-Peptide Tetramer in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of MHC-Peptide Tetramer companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, revenue for each segment.

Chapter 8: China by Type, and by Application, revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, MHC-Peptide Tetramer revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions Show more